BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20555141)

  • 1. Phosphorylation alters tau distribution and elongates life span in Drosophila.
    Yeh PA; Chang CJ; Tu PH; Wilson HI; Chien JY; Tang CY; Su MT
    J Alzheimers Dis; 2010; 21(2):543-56. PubMed ID: 20555141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
    Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
    J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.
    Talmat-Amar Y; Arribat Y; Redt-Clouet C; Feuillette S; Bougé AL; Lecourtois M; Parmentier ML
    Hum Mol Genet; 2011 Oct; 20(19):3738-45. PubMed ID: 21705366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic restraint stress alters the expression and distribution of phosphorylated tau and MAP2 in cortex and hippocampus of rat brain.
    Yan J; Sun XB; Wang HQ; Zhao H; Zhao XY; Xu YX; Guo JC; Zhu CQ
    Brain Res; 2010 Aug; 1347():132-41. PubMed ID: 20513368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights from Drosophila models of Alzheimer's disease.
    Cowan CM; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Aug; 38(4):988-92. PubMed ID: 20658990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK3: a possible link between beta amyloid peptide and tau protein.
    Hernández F; Gómez de Barreda E; Fuster-Matanzo A; Lucas JJ; Avila J
    Exp Neurol; 2010 Jun; 223(2):322-5. PubMed ID: 19782073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles.
    Wittmann CW; Wszolek MF; Shulman JM; Salvaterra PM; Lewis J; Hutton M; Feany MB
    Science; 2001 Jul; 293(5530):711-4. PubMed ID: 11408621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease.
    Pérez M; Morán MA; Ferrer I; Avila J; Gómez-Ramos P
    Acta Neuropathol; 2008 Oct; 116(4):409-18. PubMed ID: 18679696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spatial and temporal distribution of intracellular free cholesterol in brains of a Niemann-Pick type C mouse model showing hyperphosphorylated tau protein. Implications for Alzheimer's disease.
    Treiber-Held S; Distl R; Meske V; Albert F; Ohm TG
    J Pathol; 2003 May; 200(1):95-103. PubMed ID: 12692847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Constitutive Dyrk1A is abnormally expressed in Alzheimer disease, Down syndrome, Pick disease, and related transgenic models.
    Ferrer I; Barrachina M; Puig B; Martínez de Lagrán M; Martí E; Avila J; Dierssen M
    Neurobiol Dis; 2005 Nov; 20(2):392-400. PubMed ID: 16242644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Alzheimer-like pathological human tau induces a behavioral motor and olfactory learning deficit in Drosophila melanogaster.
    Beharry C; Alaniz ME; Alonso Adel C
    J Alzheimers Dis; 2013; 37(3):539-50. PubMed ID: 23948901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tau phosphorylation by diisopropyl phosphorofluoridate (DFP)-treated hen brain supernatant inhibits its binding with microtubules: role of Ca2+/Calmodulin-dependent protein kinase II in tau phosphorylation.
    Gupta RP; Abou-Donia MB
    Arch Biochem Biophys; 1999 May; 365(2):268-78. PubMed ID: 10328822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus-mediated expression of the axonal protein tau in human model neurons (NT2-N cells).
    Fath T; Eidenmüller J; Maas T; Brandt R
    Microsc Res Tech; 2000 Jan; 48(2):85-96. PubMed ID: 10649509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.
    Cowan CM; Chee F; Shepherd D; Mudher A
    Biochem Soc Trans; 2010 Apr; 38(2):564-70. PubMed ID: 20298222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulated amyloid-beta peptide and hyperphosphorylated tau protein: relationship and links in Alzheimer's disease.
    Huang HC; Jiang ZF
    J Alzheimers Dis; 2009; 16(1):15-27. PubMed ID: 19158417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p44mpk MAP kinase induces Alzheimer type alterations in tau function and in primary hippocampal neurons.
    Lu Q; Soria JP; Wood JG
    J Neurosci Res; 1993 Jul; 35(4):439-44. PubMed ID: 7689658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A putative role for cell cycle-related proteins in microtubule-based neuroplasticity.
    Schmetsdorf S; Arnold E; Holzer M; Arendt T; Gärtner U
    Eur J Neurosci; 2009 Mar; 29(6):1096-107. PubMed ID: 19302146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invertebrate models of Alzheimer's disease.
    Link CD
    Genes Brain Behav; 2005 Apr; 4(3):147-56. PubMed ID: 15810903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microtubule destruction induces tau liberation and its subsequent phosphorylation.
    Miyasaka T; Sato S; Tatebayashi Y; Takashima A
    FEBS Lett; 2010 Jul; 584(14):3227-32. PubMed ID: 20561519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of the
    Veselkina ER; Trostnikov MV; Roshina NV; Pasyukova EG
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.